The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
MicroRNA-Global Market Insights and Sales Trends 2024
Synopsis
A microRNA (abbreviated miRNA) is a small non-coding RNA molecule (containing about 22 nucleotides) found in plants, animals and some viruses, that functions in RNA silencing and post-transcriptional regulation of gene expression.
The global MicroRNA market size is expected to reach US$ 1837.9 million by 2029, growing at a CAGR of 17.3% from 2023 to 2029. The market is mainly driven by the significant applications of MicroRNA in various end use industries. The expanding demands from the Diagnostic Centers, Academic and Research Institutes, Biopharmaceutical Companies and Contract Research Organizations, are propelling MicroRNA market. PCR-based Assay, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the miRNA Arrays segment is estimated at % CAGR for the next seven-year period.
PCR based arrays dominated the global microRNA market in revenue terms in 2017, and the trend is projected to continue throughout the forecast period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for MicroRNA, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global MicroRNA market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global MicroRNA market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, MicroRNA sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of MicroRNA covered in this report include Illumina, Roche, Agilent, Bio-Rad, Sigma Aldrich, Qiagen, Thermo Fisher Scientific, HTG Molecular Diagnostics and Meridian Life Science, etc.
The global MicroRNA market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina
Roche
Agilent
Bio-Rad
Sigma Aldrich
Qiagen
Thermo Fisher Scientific
HTG Molecular Diagnostics
Meridian Life Science
Rosetta Genomics
Dharmacon
BioVendor
Miltenyi Biotec
Kaneka Corporation
Abcam
GeneCopoeia
Promega Corporation
New England Biolabs
NanoString Technologies
Global MicroRNA market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global MicroRNA market, Segment by Type:
PCR-based Assay
miRNA Arrays
Next Generation Sequencing (NGS)
Immunoassay
Global MicroRNA market, by Application
Diagnostic Centers
Academic and Research Institutes
Biopharmaceutical Companies
Contract Research Organizations
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of MicroRNA companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
A microRNA (abbreviated miRNA) is a small non-coding RNA molecule (containing about 22 nucleotides) found in plants, animals and some viruses, that functions in RNA silencing and post-transcriptional regulation of gene expression.
The global MicroRNA market size is expected to reach US$ 1837.9 million by 2029, growing at a CAGR of 17.3% from 2023 to 2029. The market is mainly driven by the significant applications of MicroRNA in various end use industries. The expanding demands from the Diagnostic Centers, Academic and Research Institutes, Biopharmaceutical Companies and Contract Research Organizations, are propelling MicroRNA market. PCR-based Assay, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the miRNA Arrays segment is estimated at % CAGR for the next seven-year period.
PCR based arrays dominated the global microRNA market in revenue terms in 2017, and the trend is projected to continue throughout the forecast period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for MicroRNA, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global MicroRNA market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global MicroRNA market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, MicroRNA sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of MicroRNA covered in this report include Illumina, Roche, Agilent, Bio-Rad, Sigma Aldrich, Qiagen, Thermo Fisher Scientific, HTG Molecular Diagnostics and Meridian Life Science, etc.
The global MicroRNA market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina
Roche
Agilent
Bio-Rad
Sigma Aldrich
Qiagen
Thermo Fisher Scientific
HTG Molecular Diagnostics
Meridian Life Science
Rosetta Genomics
Dharmacon
BioVendor
Miltenyi Biotec
Kaneka Corporation
Abcam
GeneCopoeia
Promega Corporation
New England Biolabs
NanoString Technologies
Global MicroRNA market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global MicroRNA market, Segment by Type:
PCR-based Assay
miRNA Arrays
Next Generation Sequencing (NGS)
Immunoassay
Global MicroRNA market, by Application
Diagnostic Centers
Academic and Research Institutes
Biopharmaceutical Companies
Contract Research Organizations
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of MicroRNA companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of MicroRNA
1.1 MicroRNA Market Overview
1.1.1 MicroRNA Product Scope
1.1.2 MicroRNA Market Status and Outlook
1.2 Global MicroRNA Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global MicroRNA Market Size by Region (2018-2029)
1.4 Global MicroRNA Historic Market Size by Region (2018-2023)
1.5 Global MicroRNA Market Size Forecast by Region (2024-2029)
1.6 Key Regions, MicroRNA Market Size (2018-2029)
1.6.1 North America MicroRNA Market Size (2018-2029)
1.6.2 Europe MicroRNA Market Size (2018-2029)
1.6.3 Asia-Pacific MicroRNA Market Size (2018-2029)
1.6.4 Latin America MicroRNA Market Size (2018-2029)
1.6.5 Middle East & Africa MicroRNA Market Size (2018-2029)
2 MicroRNA Market by Type
2.1 Introduction
2.1.1 PCR-based Assay
2.1.2 miRNA Arrays
2.1.3 Next Generation Sequencing (NGS)
2.1.4 Immunoassay
2.2 Global MicroRNA Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global MicroRNA Historic Market Size by Type (2018-2023)
2.2.2 Global MicroRNA Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America MicroRNA Revenue Breakdown by Type (2018-2029)
2.3.2 Europe MicroRNA Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific MicroRNA Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America MicroRNA Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa MicroRNA Revenue Breakdown by Type (2018-2029)
3 MicroRNA Market Overview by Application
3.1 Introduction
3.1.1 Diagnostic Centers
3.1.2 Academic and Research Institutes
3.1.3 Biopharmaceutical Companies
3.1.4 Contract Research Organizations
3.2 Global MicroRNA Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global MicroRNA Historic Market Size by Application (2018-2023)
3.2.2 Global MicroRNA Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America MicroRNA Revenue Breakdown by Application (2018-2029)
3.3.2 Europe MicroRNA Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific MicroRNA Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America MicroRNA Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa MicroRNA Revenue Breakdown by Application (2018-2029)
4 MicroRNA Competition Analysis by Players
4.1 Global MicroRNA Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in MicroRNA as of 2022)
4.3 Date of Key Players Enter into MicroRNA Market
4.4 Global Top Players MicroRNA Headquarters and Area Served
4.5 Key Players MicroRNA Product Solution and Service
4.6 Competitive Status
4.6.1 MicroRNA Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Illumina
5.1.1 Illumina Profile
5.1.2 Illumina Main Business
5.1.3 Illumina MicroRNA Products, Services and Solutions
5.1.4 Illumina MicroRNA Revenue (US$ Million) & (2018-2023)
5.1.5 Illumina Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche MicroRNA Products, Services and Solutions
5.2.4 Roche MicroRNA Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Recent Developments
5.3 Agilent
5.3.1 Agilent Profile
5.3.2 Agilent Main Business
5.3.3 Agilent MicroRNA Products, Services and Solutions
5.3.4 Agilent MicroRNA Revenue (US$ Million) & (2018-2023)
5.3.5 Bio-Rad Recent Developments
5.4 Bio-Rad
5.4.1 Bio-Rad Profile
5.4.2 Bio-Rad Main Business
5.4.3 Bio-Rad MicroRNA Products, Services and Solutions
5.4.4 Bio-Rad MicroRNA Revenue (US$ Million) & (2018-2023)
5.4.5 Bio-Rad Recent Developments
5.5 Sigma Aldrich
5.5.1 Sigma Aldrich Profile
5.5.2 Sigma Aldrich Main Business
5.5.3 Sigma Aldrich MicroRNA Products, Services and Solutions
5.5.4 Sigma Aldrich MicroRNA Revenue (US$ Million) & (2018-2023)
5.5.5 Sigma Aldrich Recent Developments
5.6 Qiagen
5.6.1 Qiagen Profile
5.6.2 Qiagen Main Business
5.6.3 Qiagen MicroRNA Products, Services and Solutions
5.6.4 Qiagen MicroRNA Revenue (US$ Million) & (2018-2023)
5.6.5 Qiagen Recent Developments
5.7 Thermo Fisher Scientific
5.7.1 Thermo Fisher Scientific Profile
5.7.2 Thermo Fisher Scientific Main Business
5.7.3 Thermo Fisher Scientific MicroRNA Products, Services and Solutions
5.7.4 Thermo Fisher Scientific MicroRNA Revenue (US$ Million) & (2018-2023)
5.7.5 Thermo Fisher Scientific Recent Developments
5.8 HTG Molecular Diagnostics
5.8.1 HTG Molecular Diagnostics Profile
5.8.2 HTG Molecular Diagnostics Main Business
5.8.3 HTG Molecular Diagnostics MicroRNA Products, Services and Solutions
5.8.4 HTG Molecular Diagnostics MicroRNA Revenue (US$ Million) & (2018-2023)
5.8.5 HTG Molecular Diagnostics Recent Developments
5.9 Meridian Life Science
5.9.1 Meridian Life Science Profile
5.9.2 Meridian Life Science Main Business
5.9.3 Meridian Life Science MicroRNA Products, Services and Solutions
5.9.4 Meridian Life Science MicroRNA Revenue (US$ Million) & (2018-2023)
5.9.5 Meridian Life Science Recent Developments
5.10 Rosetta Genomics
5.10.1 Rosetta Genomics Profile
5.10.2 Rosetta Genomics Main Business
5.10.3 Rosetta Genomics MicroRNA Products, Services and Solutions
5.10.4 Rosetta Genomics MicroRNA Revenue (US$ Million) & (2018-2023)
5.10.5 Rosetta Genomics Recent Developments
5.11 Dharmacon
5.11.1 Dharmacon Profile
5.11.2 Dharmacon Main Business
5.11.3 Dharmacon MicroRNA Products, Services and Solutions
5.11.4 Dharmacon MicroRNA Revenue (US$ Million) & (2018-2023)
5.11.5 Dharmacon Recent Developments
5.12 BioVendor
5.12.1 BioVendor Profile
5.12.2 BioVendor Main Business
5.12.3 BioVendor MicroRNA Products, Services and Solutions
5.12.4 BioVendor MicroRNA Revenue (US$ Million) & (2018-2023)
5.12.5 BioVendor Recent Developments
5.13 Miltenyi Biotec
5.13.1 Miltenyi Biotec Profile
5.13.2 Miltenyi Biotec Main Business
5.13.3 Miltenyi Biotec MicroRNA Products, Services and Solutions
5.13.4 Miltenyi Biotec MicroRNA Revenue (US$ Million) & (2018-2023)
5.13.5 Miltenyi Biotec Recent Developments
5.14 Kaneka Corporation
5.14.1 Kaneka Corporation Profile
5.14.2 Kaneka Corporation Main Business
5.14.3 Kaneka Corporation MicroRNA Products, Services and Solutions
5.14.4 Kaneka Corporation MicroRNA Revenue (US$ Million) & (2018-2023)
5.14.5 Kaneka Corporation Recent Developments
5.15 Abcam
5.15.1 Abcam Profile
5.15.2 Abcam Main Business
5.15.3 Abcam MicroRNA Products, Services and Solutions
5.15.4 Abcam MicroRNA Revenue (US$ Million) & (2018-2023)
5.15.5 Abcam Recent Developments
5.16 GeneCopoeia
5.16.1 GeneCopoeia Profile
5.16.2 GeneCopoeia Main Business
5.16.3 GeneCopoeia MicroRNA Products, Services and Solutions
5.16.4 GeneCopoeia MicroRNA Revenue (US$ Million) & (2018-2023)
5.16.5 GeneCopoeia Recent Developments
5.17 Promega Corporation
5.17.1 Promega Corporation Profile
5.17.2 Promega Corporation Main Business
5.17.3 Promega Corporation MicroRNA Products, Services and Solutions
5.17.4 Promega Corporation MicroRNA Revenue (US$ Million) & (2018-2023)
5.17.5 Promega Corporation Recent Developments
5.18 New England Biolabs
5.18.1 New England Biolabs Profile
5.18.2 New England Biolabs Main Business
5.18.3 New England Biolabs MicroRNA Products, Services and Solutions
5.18.4 New England Biolabs MicroRNA Revenue (US$ Million) & (2018-2023)
5.18.5 New England Biolabs Recent Developments
5.19 NanoString Technologies
5.19.1 NanoString Technologies Profile
5.19.2 NanoString Technologies Main Business
5.19.3 NanoString Technologies MicroRNA Products, Services and Solutions
5.19.4 NanoString Technologies MicroRNA Revenue (US$ Million) & (2018-2023)
5.19.5 NanoString Technologies Recent Developments
6 North America
6.1 North America MicroRNA Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe MicroRNA Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific MicroRNA Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America MicroRNA Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa MicroRNA Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 MicroRNA Market Dynamics
11.1 MicroRNA Industry Trends
11.2 MicroRNA Market Drivers
11.3 MicroRNA Market Challenges
11.4 MicroRNA Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
